ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,426, issued on Sept. 29, was assigned to Spark Biomedical Inc. (Dallas).
"Ex-vivo enhancement of platelet function during blood processing" was invented by Alejandro Covalin (Los Angeles) and Navid Khodaparast (Dallas).
According to the abstract* released by the U.S. Patent & Trademark Office: "In an illustrative embodiment, enhancing platelet function ex-vivo includes treating blood (e.g., whole blood or separated platelets) extracted from a subject with calcium ions and one or more reagents, each reagent configured to activate at least one transmembrane Ca2+ channel, such that the combined calcium ions and reagent(s) cause a portion of platelets within the blood to undergo enh...